Stocks / NASDAQ / Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc.

Our Opinion

Ocular Therapeutix, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“We plan to continue our collaborative programs with the goal of establishing feasibility, which would require acceptable tolerability in rabbit eyes and acceptable pharmacokinetic data in an appropriate animal model.” Read the full document

Company Description

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its products include dextenza, sustained release travopost, and posterior segment injections. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA. [Source: MarketWatch]

Company Website: